Stocktoria
Sarepta Therapeutics, Inc. SRPT
Sarepta Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 10,324,404 | $1.6B | 9.84% |
| TWO SIGMA INVESTMENTS, LP | 4,598,735 | $82.6M | 4.38% |
| AQR CAPITAL MANAGEMENT LLC | 4,325,689 | $76.9M | 4.12% |
| CITADEL ADVISORS LLC | 1,544,100 | $27.7M | 1.47% |
| MILLENNIUM MANAGEMENT LLC | 1,193,468 | $21.4M | 1.14% |
| RENAISSANCE TECHNOLOGIES LLC | 1,121,378 | $20.2M | 1.07% |
| Point72 Asset Management, L.P. | 510,908 | $9.2M | 0.49% |
| Bridgewater Associates, LP | 152,068 | $2.7M | 0.14% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.